Company Analysis

XBiotech Inc. (XBIT)

Nasdaq: XBIT · Pharmaceutical Preparations · Austin, TX · filing with the SEC since 2014
Grade5.3
◀ Past 4.8● Present 5.0▶ Future 6.0
4 est.

Who runs XBiotech Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Simard Jan-Paul
Co-Chief Executive Officer. First filing Oct 2026, latest Oct 28, 2026, 0 filings in all.
Officers reporting now
2
of 6 people with a filing in the last fifteen months
Directors reporting now
4
21 people on the record since 2015
Officerssales are open-market, Oct 28, 2025 to Oct 28, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Simard Jan-PaulCo-Chief Executive OfficerOct 2026Oct 28, 2026none
Simard JohnChief Executive OfficerApr 2015Oct 28, 2026none
Directorssales are open-market, Oct 28, 2025 to Oct 28, 2026
NameRoleFirst filingLatest filingSales, 12 months
Kuendig Thomas MartindirectorSep 2025Nov 12, 2025none
Rademaker Craig EvandirectorSep 2025Nov 12, 2025none
Soffer David SpencerdirectorSep 2025Nov 12, 2025none
Troy Tevi DaviddirectorSep 2025Nov 12, 2025none
Earlier names on the record18, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton XBIT · research, not advice